Skip to main content

Table 3 Comparison of secondary outcomes between treatment groupsb

From: Effects of acupuncture at acupoints with lower versus higher pain threshold for knee osteoarthritis: a multicenter randomized controlled trial

Secondary outcomes measurea

LPT group vs HPT group

LPT group vs WL group

HPT group vs WL group

Mean difference (95% CI)

P value

Mean difference (95% CI)

P value

Mean difference (95% CI)

P value

WOMAC pain

 Baseline

–

–

–

–

–

–

 4 weeks

−0.01 (−1.06 to 1.03)

0.98

−2.28 (−3.32 to −1.25)

 < 0.001

−2.27 (−1.31 to −1.23)

 < 0.001

 8 weeks

−0.14 (−1.19 to 0.91)

0.80

−2.63 (−3.68 to −1.59)

 < 0.001

−2.49 (−3.53 to −1.45)

 < 0.001

 12 weeks

0.45 (−0.60 to 1.51)

0.40

−2.16 (−3.20 to −1.11)

 < 0.001

−2.61 (−3.66 to −1.57)

 < 0.001

 16 weeks

0.26 (−0.79 to 1.31)

0.63

−2.47 (−3.51 to −1.43)

 < 0.001

−2.73 (−3.77 to −1.69)

 < 0.001

WOMAC stiffness

 Baseline

–

–

–

–

–

–

 4 weeks

−0.16 (−0.67 to 0.34)

0.52

−0.93 (−1.42 to −0.43)

< 0.001

−0.76 (−1.26 to −0.26)

0.003

 8 weeks

−0.16 (−0.66 to 0.35)

0.54

−0.81 (−1.31 to −0.30)

0.002

−0.65 (−1.15 to −0.15)

0.01

 12 weeks

−0.13 (−0.64 to 0.38)

0.61

−0.85 (−1.35 to −0.35)

0.001

−0.72 (−1.22 to −0.21)

0.005

 16 weeks

−0.06 (−0.57 to 0.44)

0.80

−0.71 (−1.22 to −0.21)

0.005

−0.65 (−1.15 to −0.15)

0.01

WOMAC function

 Baseline

–

–

–

–

–

–

 4 weeks

1.38 (−2.12 to 4.87)

0.44

−7.56 (−11.03 to −4.10)

 < 0.001

−8.94 (−12.04 to −5.48)

 < 0.001

 8 weeks

0.48 (−3.03 to 4.00)

0.79

−7.45 (−10.93 to −3.96)

 < 0.001

−7.93 (−11.41 to −4.45)

 < 0.001

 12 weeks

2.63 (−0.89 to 6.16)

0.14

−6.02 (−9.51 to −2.52)

 < 0.001

−8.65 (−12.14 to −5.17)

 < 0.001

 16 weeks

2.32 (−1.18 to 5.83)

0.19

−7.22 (−10.70 to −3.74)

 < 0.001

−9.55 (−13.02 to −6.08)

 < 0.001

SF-12 PCS

 Baseline

–

–

–

–

–

–

 4 weeks

1.09 (−0.16 to 2.34)

0.09

2.75 (1.51 to 3.99)

 < 0.001

1.66 (0.42 to 2.90)

0.008

 8 weeks

−0.47 (−1.74 to 0.79)

0.47

1.55 (0.30 to 2.81)

0.015

2.02 (0.77 to 3.27)

0.002

 12 weeks

0.62 (−0.65 to 1.89)

0.34

1.93 (0.67 to 3.18)

0.003

1.30 (0.05 to 2.56)

0.04

 16 weeks

0.10 (−1.15 to 1.36)

0.87

1.97 (0.72 to 3.21)

0.002

1.86 (0.62 to 3.11)

0.003

SF-12 MCS

 Baseline

–

–

–

–

–

–

 4 weeks

−0.12 (−1.50 to 1.26)

0.86

−0.22 (−1.58 to 1.14)

0.75

−0.10 (−1.46 to 1.26)

0.88

 8 weeks

0.15 (−1.24 to 1.54)

0.83

0.93 (−0.45 to 2.30)

0.19

0.78 (−0.60 to 2.15)

0.27

 12 weeks

−0.50 (−1.89 to 0.90)

0.48

−0.17 (−1.55 to 1.22)

0.81

0.33 (−1.04 to 1.71)

0.64

 16 weeks

−0.33 (−1.71 to 1.06)

0.64

0.56 (−0.81 to 1.93)

0.42

0.89 (−0.48 to 2.26)

0.2

Knee flexion ROM

      

 Baseline

–

–

–

–

–

–

 4 weeks

0.79 (−0.97 to 2.54)

0.38

4.33 (2.59 to 6.08)

 < 0.001

3.55 (1.81 to 5.29)

 < 0.001

 8 weeks

1.03 (−0.77 to 2.83)

0.26

3.32 (1.53 to 5.11)

 < 0.001

2.30 (0.51 to 4.08)

0.01

 12 weeks

0.88 (−0.99 to 2.74)

0.36

1.05 (−0.80 to 2.90

0.24

0.17 (−1.66 to 2.01)

0.85

 16 weeks

0.53 (−1.36 to 2.42)

0.58

1.79 (−0.08 to 3.66)

0.06

1.25 (−0.60 to 3.11)

0.19

Knee extension ROM

      

 Baseline

–

–

–

–

–

–

 4 weeks

0.13 (0.02 to 0.25)

0.02

0.06 (−0.06 to 0.18)

0.32

−0.07 (−0.19 to 0.04)

0.21

 8 weeks

0.02 (−0.10 to 0.14)

0.79

0.10 (−0.02 to 0.21)

0.12

0.08 (−0.04 to 0.20)

0.2

 12 weeks

0.05 (−0.08 to 0.17)

0.48

0.13 (0.01 to 0.25)

0.04

0.08 (−0.04 to 0.21)

0.17

 16 weeks

0.03 (−0.10 to 0.15)

0.68

0.10 (−0.02 to 0.23)

0.1

0.08 (−0.05 to 0.20)

0.22

Knee internal rotation ROM

      

 Baseline

–

–

–

–

–

–

 4 weeks

0.44 (−0.73 to 1.62)

0.46

1.28 (0.12 to 2.45)

0.03

0.84 (−0.33 to 2.00)

0.16

 8 weeks

0.09 (−1.12 to 1.30)

0.89

1.61 (0.41 to 2.81)

0.009

1.52 (0.32 to 2.72)

0.01

 12 weeks

0.14 (−1.12 to 1.39)

0.83

1.89 (0.65 to 3.12)

0.003

1.75 (0.52 to 2.98)

0.005

 16 weeks

0.24 (−1.03 to 1.51)

0.71

0.52 (−0.74 to 1.77)

0.42

0.28 (−0.96 to 1.53)

0.66

Knee external rotation ROM

      

 Baseline

–

 

–

 

–

–

 4 weeks

−0.42 (−1.63 to 0.80)

0.50

0.88 (−0.33 to 2.08)

0.15

1.30 (0.09 to 2.50)

0.03

 8 weeks

0.34 (−0.90 to 1.59)

0.59

1.49 (0.16 to 2.63)

0.03

1.05 (−0.18 to 2.29)

0.09

 12 weeks

0.43 (−0.86 to 1.71)

0.52

0.56 (−0.72 to 1.83)

0.39

0.13 (−1.13 to 1.40)

0.84

 16 weeks

−0.44 (−1.74 to 0.87)

0.51

0.70 (−0.59 to 2.00)

0.28

1.14 (−0.14 to 2.42)

0.08

  1. LPT lower pain threshold, HPT higher pain threshold, WL waiting-list
  2. aMissing data not imputed for secondary outcomes analyses
  3. bAdjusted analysis was performed using a liner mixed model with baseline value as covariate, treatment, visit, and interaction between treatment and visit as fixed effects, sites and individuals as random effects